Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

June 27, 2013

PAR PHARMACEUTICAL, INC. et al v. BRECKENRIDGE PHARMACEUTICAL, INC.

Track this case

Case Number:

2:13-cv-04000

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Kevin McNulty

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 02, 2013

    Par, Alkermes Sue Breckenridge To Block Generic Megace

    Par Pharmaceutical Inc. and Alkermes Pharma Ireland Ltd. brought patent infringement allegations in New Jersey federal court Thursday against Breckenridge Pharmaceutical Inc. over the company's plans to make a generic version of the appetite stimulant drug Megace ES.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login